ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis

Zhang, Chao; Chen, Hua-Fei; Yan, Shi; Wu, Lin; Yan, Li-Xu; Yan, Xiao-Long; Yue, Dong-Sheng; Xu, Chun-Wei; Zheng, Min; Li, Ji-Sheng; Liu, Si-Yang; Yang, Ling-Ling; Jiang, Ben-Yuan; Ou, Qiu-Xiang; Qiu, Zhen-Bin; Shao, Yang; Wu, Yi-Long; Zhong, Wen-Zhao*广东省人民医院; 北京大学; 南京大学; 山东大学; 中国人民解放军第四军医大学
npj Precision Oncology2022-9-19DOI: 10.1038/s41698-022-00301-8
10被引6阅读
引用收藏
分享

摘要

Despite limited efficacy of immunotherapy for advanced non-small-cell lung cancer (NSCLC) with driver mutations, whether neoadjuvant immunotherapy could be clinically valuable in those patients warrants further investigation. We utilized 40 oncogenemutant NSCLC treated with induction immunotherapy from a large consecutive multicenter cohort. Overall response rate was 62.5% while 2 patients had disease progression. Of 39 patients that received surgery, RO resection rate was 97.4%. The major pathological response (MPR) rate was 37.5% and the pathological complete response (pCR) rate was 12.5%. Pre-treatment PD-L1 expression was not a predictive biomarker in these patients. Median disease-free survival for all oncogenic mutation and EGFR mutation was 28.5 months. Indirect comparison through integrating CTONG1103 cohort showed neoadjuvant immunotherapy plus chemotherapy yielded the most superior efficacy among erlotinib and chemotherapy for resectable EGFR-mutant NSCLC. No MPR patients were identified with neoadjuvant immunotherapy plus chemotherapy for uncommon EGFR insertion or point mutations. Our results indicated the potential clinical feasibility of neoadjuvant immunotherapy for resectable localized oncogene-mutant NSCLC especially for EGFR-mutant NSCLC.

学科与关键词

关键词
CELL LUNG-CANCERNEOADJUVANT CHEMOTHERAPYGENETIC-HETEROGENEITYSINGLE-ARMOPEN-LABELIMMUNOTHERAPYNIVOLUMABDOCETAXELBLOCKADETHERAPY
相关
加载中…
  • Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art
    Kang, Jin; Zhang, Chao; Zhong, Wen-Zhao*Cancer Communications, 2021, 41(4): 287-302.被引 62
  • Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study
    Liu, Si-Yang; Dong, Song; Yang, Xue-Ning; Liao, Ri-Qiang; Jiang, Ben-Yuan; Wang, Qun; Ben, Xiao-Song; Qiao, Gui-Bin; Lin, Jun-Tao; Yan, Hong-Hong; Yan, Li-Xu; Nie, Qiang; Tu, Hai-Yan; Wang, Bin-Chao; Yang, Jin-Ji; Zhou, Qing; Li, Hong-Rui; Liu, Ke; Wu, Wendy; Liu, Si-Yang Maggie; Zhong, Wen-Zhao*; Wu, Yi-Long*Signal Transduction and Targeted Therapy, 2023, 8(1): 442.
  • Genomic and immune characteristics of HER2-mutated non-small-cell lung cancer and response to immune checkpoint inhibitor-based therapy
    Tu, Hai-Yan; Yin, Kai; Zhao, Xiaotian; Ke, E-E; Wu, Si-Pei; Li, Yang-Si; Zheng, Mei-Mei; Liu, Si-Yang Maggie; Xu, Chong-Rui; Sun, Yue-Li; Lin, Jia-Xin; Bai, Xiao-Yan; Zhang, Yi-Chen; Zhou, Qing; Yang, Jin-Ji; Zhong, Wen-Zhao; Wang, Bing-Chao; Zhang, Xu-Chao; Zhu, Dongqin; Yang, Lingling; Ou, Qiuxiang; Wu, Yi-Long*Molecular Oncology, 2023, 17(8): 1581-1594.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
npj Precision Oncology
发表日期
2022-09-19
卷期
第 6 卷, 第 1 期
页码
66
DOI
10.1038/s41698-022-00301-8
期刊等级
2区
成果收录
SCIE
资助标注
National Natural Science Foundation [81872510]; High-level Hospital Construction Project [DFJH201801]

作者

  • Z

    Zhang, Chao (第一作者)

    guangdong prov peoples hosp

  • C

    Chen, Hua-Fei

查看全部 18 位作者收起作者
  • Y

    Yan, Shi

    2 · peking univ

  • W

    Wu, Lin

  • Y

    Yan, Li-Xu

    guangdong prov peoples hosp

  • Y

    Yan, Xiao-Long

    fourth mil med univ

  • Y

    Yue, Dong-Sheng

    tianjin med univ

  • X

    Xu, Chun-Wei

    nanjing univ

  • Z

    Zheng, Min

    guilin med univ

  • L

    Li, Ji-Sheng

    shandong univ

  • L

    Liu, Si-Yang

  • Y

    Yang, Ling-Ling

  • J

    Jiang, Ben-Yuan

    guangdong prov peoples hosp

  • O

    Ou, Qiu-Xiang

  • Q

    Qiu, Zhen-Bin

    guangdong prov peoples hosp

  • S

    Shao, Yang

  • W

    Wu, Yi-Long

    guangdong prov peoples hosp

  • Z

    Zhong, Wen-Zhao (通讯)

    guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417